In its full extent, the range of BPC 157 therapy and its huge curing potential as a treatment (for review, see [1,3,4,5,6,8,9,32,33,34,92]) might largely override the range of the beneficial effects commonly reported with standard cytoprotective agents (for review, see [35,36,37,38,39,40,41,42]) (i.e., prostaglandins beneficial effects on the stomach [35], intestine [38], liver [130], pancreas [39], kidney [38,131], and heart [132])
It is NOT for human consumption, self-experimentation, or athletic recovery
Synergistic antimicrobial effect of the combination of beta-lactam antibiotics and chitosan derivative on multidrug-resistant bacteria
and best practices in meeting the needs of victims
J Clin Pathol (2008) 61:6236